CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
Nature Medicine2016Vol. 22(3), pp. 278–287
Citations Over TimeTop 1% of 2016 papers
Elisa M. Noll, Christian Eisen, Albrecht Stenzinger, Elisa Espinet, Alexander Muckenhuber, Corinna Klein, Vanessa Vogel, Bernd Klaus, Wiebke Nadler, Christoph Rösli, Christian Lutz, Michael Kulke, Jan Engelhardt, Franziska Maria Zickgraf, Octavio Espinosa, Matthias Schlesner, Xiaoqi Jiang, Annette Kopp‐Schneider, P. Neuhaus, Marcus Bahra, Bruno V. Sinn, Roland Eils, Nathalia A. Giese, Thilo Hackert, Oliver Strobel, Jens Werner, Markus W. Büchler, Wilko Weichert, Andreas Trumpp, Martin R. Sprick
Related Papers
- → Enzyme-Instructed Assembly and Disassembly Processes for Targeting Downregulation in Cancer Cells(2017)146 cited
- → Upregulation of β3-adrenoceptors—a general marker of and protective mechanism against hypoxia?(2019)10 cited
- → Downregulation of POLD4 in Calu6 cells results in G1-S blockage through suppression of the Akt-Skp2-p27 pathway(2014)8 cited
- → Downregulation of p21/WAF1 Expression by Thymidylate Synthase(2001)17 cited
- → Viral Infection and Abnormal Brain Development: A DNA Microarray Study(2007)1 cited